Status:

NOT_YET_RECRUITING

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

Lead Sponsor:

University of California, Los Angeles

Conditions:

Knee Osteoarthritis

Depression

Eligibility:

All Genders

50-95 years

Phase:

EARLY_PHASE1

Brief Summary

Osteoarthritis (OA) is a major public health problem, and involvement of the knee is especially disabling. Symptomatic knee OA has an incidence rate between 40 to 1,020 per 100,000 person years1 and i...

Detailed Description

Major depressive disorder (MDD) and chronic pain are highly comorbid, especially in women. Pain symptoms can either precede or follow the onset of MDD, suggesting a bidirectional relationship between ...

Eligibility Criteria

Inclusion

  • • Age 50 or years older.
  • Chronic pain as indicated by complaints of pain in one or more body regions for 6 months or more. Participants who meet at least one of the following criteria for Osteoarthritis (OA)
  • Fulfills the American College of Rheumatology (ACR) criteria for symptomatic knee OA and had radiographic evidence of tibiofemoral or patellofemoral OA (defined as the presence of a definite osteophyte in the tibiofemoral compartment and/or the patellofemoral compartment.
  • Knee pain for \>- 3 months and on most days of the past month
  • Patient PROMIS Pain Interference score \>=40 (100 mm VAS);
  • Access to computer or device for telehealth delivery;
  • Able to walk without cane or assistance.
  • Psychological distress expressed as depression: Persistent depressive symptomatology (Beck Depression Inventory)\>20 in two consecutive screenings within 2-3 weeks.
  • Willingness to complete the 3-month study, including twice-a-week Tai Chi sessions and rTMS, with additional 6 and 12 month follow up
  • Approval to participate in program by patient's primary care provider or another member of their medical team (e.g. cardiologist).
  • Ability to pass the Physical Activity Readiness Questionnaire (PAR-Q) administered in the telephone screening.
  • Internet access \>No contraindications to rTMS

Exclusion

  • • Change in psychotropic or pain medication during the past four months. This will minimize the amount of symptom change due to medication alterations.
  • A current diagnosis of mania, hypomania, unstable bipolar disorder, psychotic disorder or a history of psychosis, as noted in electronic medical record.
  • Dementia, neurological disease, cancer, cardiovascular disease, metabolic disease, renal disease, liver disease, or other serious medical conditions limiting ability to participate in the Tai Chi or Exercise programs, as determined by primary care physicians.
  • No current medical conditions that limit ability to participate safely in moderate exercise.
  • Meets criteria for alcohol or drug dependence within the past three months.
  • Currently practicing Tai Chi

Key Trial Info

Start Date :

February 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2029

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06906939

Start Date

February 1 2026

End Date

June 30 2029

Last Update

December 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UCLA Semel Institute - Neuropsychiatric Institute (NPI)

Los Angeles, California, United States, 90095